Jan-Erik Damber

• Effect of docetaxel added to bicalutamide in Hormone-Naive non-metastatic prostate cancer with rising PSA, a randomized clinical trial (SPCG-14)

  Andreas Josefsson, Åsa Jellvert, Erik Holmberg, K. Brasso, P. M. Petersen, S. Aaltomaa, M. Luukkaa, P. Verhagen, R. de Wit, G. Ahlgren, O. Andren, E. Castellanos, M. Seke, A. Widmark, Jan-Erik Damber
  Acta Oncologica - 2023
• Magnetic Resonance Imaging as a Tool for Monitoring Intratibial Growth of Experimental Prostate Cancer Metastases in Mice

  Junchi Huang, Mikael Montelius, Jan-Erik Damber, Karin Welén
  Methods and Protocols (MP) - 2023
• Osteoclasts directly influence castration-resistant prostate cancer cells.

  Junchi Huang, Eva Freyhult, Robert Buckland, Andreas Josefsson, Jan-Erik Damber, Karin Welén
  Clinical & experimental metastasis - 2022
• Clinical and biological relevance of the transcriptomic-based prostate cancer metastasis subtypes MetA-C

  E. Thysell, L. Kohn, J. Semenas, H. Jaremo, E. Freyhult, M. Lundholm, C. T. Karlsson, Jan-Erik Damber, A. Widmark, S. Crnalic, Andreas Josefsson, Karin Welén, R. J. A. Nilsson, A. Bergh, P. Wikstrom
  Molecular Oncology - 2022
• Timing of the pubertal growth spurt and prostate cancer

  Jimmy Celind, Maria Bygdell, Jari Martikainen, Johan Styrke, Jan-Erik Damber, Jenny Kindblom, Claes Ohlsson
  Cancers - 2021
• The roles of RUNX2 and osteoclasts in regulating expression of steroidogenic enzymes in castration-resistant prostate cancer cells

  Junchi Huang, Malin Hagberg Thulin, Jan-Erik Damber, Karin Welén
  Molecular and Cellular Endocrinology - 2021
• Inhibition of STAT3 prevents bone metastatic progression of prostate cancer in vivo

  Malin Hagberg Thulin, J. Maatta, Anna Linder, S. Sterbova, Claes Ohlsson, Jan-Erik Damber, A. Widmark, E. Persson
  Prostate - 2021
• Gene expression alterations during development of castration-resistant prostate cancer are detected in circulating tumor cells

  Andreas Josefsson, Karin Larsson, E. Freyhult, Jan-Erik Damber, Karin Welén
  Cancers - 2020
• Men with type 2 diabetes mellitus have a lower detection rate of prostate cancer.

  Mohammad-Ali Haghsheno, Jan Hammarsten, Ralph Peeker, Carl Johan Behre, Dan Mellström, Jan-Erik Damber
  International journal of urology : official journal of the Japanese Urological Association - 2020
• RGS2 is prognostic for development of castration resistance and cancer-specific survival in castration-resistant prostate cancer

  Anna Linder, Karin Larsson, Karin Welén, Jan-Erik Damber
  Prostate - 2020
• Targeted alpha therapy with astatine-211-labeled anti-PSCA A11 minibody shows antitumor efficacy in prostate cancer xenografts and bone microtumors

  Tom Bäck, Karin Jennbacken, Malin Hagberg Thulin, Sture Lindegren, H. Jensen, T. Olafsen, P. J. Yazaki, Stig Palm, Per Albertsson, Jan-Erik Damber, A. M. Wu, Karin Welén
  Ejnmmi Research - 2020
• Temporal changes in survival in men with de novo metastatic prostate cancer: nationwide population-based study

  M. Westerberg, Ingela Franck Lissbrant, Jan-Erik Damber, D. Robinson, H. Garmo, P. Stattin
  Acta Oncologica - 2020
• Triple treatment of high-risk prostate cancer. A matched cohort study with up to 19 years follow-up comparing survival outcomes after triple treatment and treatment with hormones and radiotherapy

  O. Gunnarsson, S. Schelin, L. Brudin, S. Carlsson, Jan-Erik Damber
  Scandinavian Journal of Urology - 2019
• AR-V7 expression in circulating tumor cells as a potential prognostic marker in metastatic hormone-sensitive prostate cancer.

  Andreas Josefsson, Jan-Erik Damber, Karin Welén
  Acta oncologica (Stockholm, Sweden) - 2019
• Androgen deprivation therapy for prostate cancer and risk of dementia

  D. Robinson, H. Garmo, M. Van Hemelrijck, Jan-Erik Damber, Ola Bratt, L. Holmberg, L. O. Wahlund, P. Stattin, J. Adolfsson
  Bju International - 2019
• FSH suppression and tumour control in patients with prostate cancer during androgen deprivation with a GnRH agonist or antagonist

  E. David Crawford, B. Tombal, T. Keane, F. Boccardo, K. Miller, N. Shore, J. W. Moul, Jan-Erik Damber, L. Collette, B-E Persson
  SCANDINAVIAN JOURNAL OF UROLOGY - 2018
• Analysis of regulator of G-protein signalling 2 (RGS2) expression and function during prostate cancer progression

  Anna Linder, M. Hagberg Thulin, Jan-Erik Damber, Karin Welén
  Scientific Reports - 2018
• Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer.

  Matthew R Smith, Fred Saad, Simon Chowdhury, Stéphane Oudard, Boris A Hadaschik, Julie N Graff, David Olmos, Paul N Mainwaring, Ji Youl Lee, Hiroji Uemura, Angela Lopez-Gitlitz, Géralyn C Trudel, Byron M Espina, Youyi Shu, Youn C Park, Wayne R Rackoff, Margaret K Yu, Eric J Small, Jan-Erik Damber
  The New England journal of medicine - 2018
• Clinical and prognostic significance of changes in haemoglobin concentration during 1 year of androgen-deprivation therapy for hormone-naïve bone-metastatic prostate cancer.

  Maria Ebbinge, Anders Berglund, Eberhard Varenhorst, Per Olov Hedlund, Gabriel Sandblom, Jan-Erik Damber
  BJU international - 2018
• Circulating tumor cells mirror bone metastatic phenotype in prostate cancer

  Andreas Josefsson, Karin Larsson, Marianne Månsson, Jens Björkman, Eva Rohlova, Daniel Åhs, Helena Brisby, Jan-Erik Damber, Karin Welén
  Oncotarget - 2018
• Castration is a prerequisite for the inhibitory effect of metronomic chemotherapy on the growth of experimental castration-resistant prostate cancer.

  Åsa Jellvert, Daniel Åhs, Josefin Olausson, Ingela Franck Lissbrant, Jan-Erik Damber, Karin Welén
  Acta oncologica (Stockholm, Sweden) - 2018
• A stage-dependent link between metabolic syndrome components and incident prostate cancer

  Jan Hammarsten, Jan-Erik Damber, Mohammad-Ali Haghsheno, Dan Mellström, Ralph Peeker
  Nature Reviews Urology - 2018
• Testosterone Replacement Therapy and Risk of Favorable and Aggressive Prostate Cancer

  S. Loeb, Y. Folkvaljon, Jan-Erik Damber, J. Alukal, M. Lambe, P. Stattin
  Journal of Clinical Oncology - 2017
• Lower prostate cancer risk in Swedish men with the androgen receptor E213 A-allele

  M. B. Holgersson, Y. Ruhayel, M. Karlsson, A. Giwercman, A. Bjartell, Claes Ohlsson, Dan Mellström, O. Ljunggren, Mohammad-Ali Haghsheno, Jan-Erik Damber, Y. L. Giwercman
  Cancer Causes & Control - 2017
• Corrigendum re: "Urinary Incontinence and Erectile Dysfunction After Robotic Versus Open Radical Prostatectomy: A Prospective, Controlled, Nonrandomised Trial" [Eur Urol 2015;68:216-25].

  Eva Haglind, Stefan Carlsson, Johan Stranne, Anna Wallerstedt, Ulrica Wilderäng, Thordis Thorsteinsdottir, Mikael Lagerkvist, Jan-Erik Damber, Anders Bjartell, Jonas Hugosson, Peter Wiklund, Gunnar Steineck
  European urology - 2017
• Circulating Tumor Cells as a Marker for Progression-free Survival in Metastatic Castration-naïve Prostate Cancer.

  Andreas Josefsson, Anna Linder, Despina Flondell Site, Giacomo Canesin, Anna Stiehm, Aseem Anand, Anders Bjartell, Jan-Erik Damber, Karin Welén
  The Prostate - 2017
• Corrigendum re: "Role of Magnetic Resonance Imaging in Prostate Cancer Screening: A Pilot Study Within the Göteborg Randomised Screening Trial" [Eur Urol 2016;70:566-73].

  Anna Grenabo Bergdahl, Ulrica Wilderäng, Gunnar Aus, S Carlsson, Jan-Erik Damber, Maria Frånlund, Kjell Geterud, Ali Khatami, Andreas Socratous, Johan Stranne, Mikael Hellström, Jonas Hugosson
  European urology - 2017
• Ten- and 15-yr Prostate Cancer-specific Mortality in Patients with Nonmetastatic Locally Advanced or Aggressive Intermediate Prostate Cancer, Randomized to Lifelong Endocrine Treatment Alone or Combined with Radiotherapy: Final Results of The Scandinavian Prostate Cancer Group-7.

  Sophie D Fosså, Fredrik Wiklund, Olbjørn Klepp, Anders Angelsen, Arne Solberg, Jan-Erik Damber, Morten Hoyer, Anders Widmark
  European urology - 2016
• Osteoblasts promote castration-resistant prostate cancer by altering intratumoral steroidogenesis.

  Malin Hagberg Thulin, Maria E. Nilsson, Pontus Thulin, Jocelyn Céraline, Claes Ohlsson, Jan-Erik Damber, Karin Welén
  Molecular and cellular endocrinology - 2016
• Tasquinimod inhibits prostate cancer growth in bone through alterations in the bone microenvironment.

  Lisa U. Magnusson, Malin Hagberg Thulin, Pascale Plas, Anders Olsson, Jan-Erik Damber, Karin Welén
  The Prostate - 2016
• Insulin-like growth factor I and risk of incident cancer in elderly men - results from MrOS (Osteoporotic Fractures in Men) in Sweden.

  Daniel Carlzon, Johan Svensson, Max Petzold, Magnus K Karlsson, Östen Ljunggren, Mohammad-Ali Haghsheno, Jan-Erik Damber, Dan Mellström, Claes Ohlsson
  Clinical endocrinology - 2016
• Degarelix monotherapy compared with luteinizing hormone-releasing hormone (LHRH) agonists plus anti-androgen flare protection in advanced prostate cancer: an analysis of two randomized controlled trials.

  Peter Iversen, Jan-Erik Damber, Anders Malmberg, Bo-Eric Persson, Laurence Klotz
  Therapeutic advances in urology - 2016
• Role of Magnetic Resonance Imaging in Prostate Cancer Screening: A Pilot Study Within the Göteborg Randomised Screening Trial.

  Anna Grenabo Bergdahl, Ulrica Wilderäng, Gunnar Aus, Sigrid Carlsson, Jan-Erik Damber, Maria Frånlund, Kjell Geterud, Ali Khatami, Andreas Socratous, Johan Stranne, Mikael Hellström, Jonas Hugosson
  European urology - 2016
• Bone Scan Index as an Imaging Biomarker in Metastatic Castration-resistant Prostate Cancer: A Multicentre Study Based on Patients Treated with Abiraterone Acetate (Zytiga) in Clinical Practice

  M. Reza, M. Ohlsson, R. Kaboteh, A. Anand, Ingela Franck Lissbrant, Jan-Erik Damber, A. Widmark, C. Thellenberg-Karlsson, L. Budäus, T. Steuber, T. Eichenauer, P. Wollmer, L. Edenbrandt, E. Trägårdh, A. Bjartell
  European Urology Focus - 2016
• Prediction of clinical progression after radical prostatectomy in a nationwide population-based cohort

  A. Bjartell, M. Bottai, J. Persson, O. Bratt, Jan-Erik Damber, P. Stattin, O. Akre
  Scandinavian Journal of Urology - 2016
• Dashboard report on performance on select quality indicators to cancer care providers.

  Pär Stattin, Fredrik Sandin, Torsten Sandbäck, Jan-Erik Damber, Ingela Franck-Lissbrant, David Robinson, Ola Bratt, Mats Lambe
  Scandinavian journal of urology - 2016
• Lower urinary tract symptoms are associated with low levels of serum serotonin, high levels of adiponectin and fasting glucose, and benign prostatic enlargement.

  Mohammad-Ali Haghsheno, Dan Mellström, Ralph Peeker, Jan Hammarsten, Mattias Lorentzon, Valter Sundh, Magnus Karlsson, Claes Ohlsson, Jan-Erik Damber
  Scandinavian journal of urology - 2015
• Satsa på MRT för diagnostik av prostatacancer.

  Ola Bratt, Göran Ahlgren, Ove Andrén, Lennart Blomqvist, Stefan Carlsson, Jan-Erik Damber, Jonas Hugosson, Fredrik Jäderling, Camilla Thellenberg Karlsson, David Robinson
  Läkartidningen - 2015
• Short-term Results after Robot-assisted Laparoscopic Radical Prostatectomy Compared to Open Radical Prostatectomy.

  Anna Wallerstedt, Stavros I Tyritzis, Thordis Thorsteinsdottir, Stefan Carlsson, Johan Stranne, Ove Gustafsson, Jonas Hugosson, Anders Bjartell, Ulrica Wilderäng, N Peter Wiklund, Gunnar Steineck, Eva Haglind, Ali Khatami, Jan-Erik Damber
  European urology - 2015
• Thromboembolic complications in 3544 patients undergoing radical prostatectomy with or without lymph node dissection.

  Stavros I Tyritzis, Anna Wallerstedt, Gunnar Steineck, Tommy Nyberg, Jonas Hugosson, Anders Bjartell, Ulrica Wilderäng, Thordis Thorsteinsdottir, Stefan Carlsson, Johan Stranne, Eva Haglind, Nils Peter Wiklund, Jan-Erik Damber
  The Journal of urology - 2015
• RE: Use of Phosphodiesterase Type 5 Inhibitors for Erectile Dysfunction and Risk of Malignant Melanoma.

  Jan-Erik Damber
  European urology - 2015
• Orteronel plus prednisone in patients with chemotherapy-naive metastatic castration-resistant prostate cancer (ELM-PC 4): a double-blind, multicentre, phase 3, randomised, placebo-controlled trial.

  Fred Saad, Karim Fizazi, Viorel Jinga, Eleni Efstathiou, Peter C Fong, Lowell L Hart, Robert Jones, Raymond McDermott, Manfred Wirth, Kazuhiro Suzuki, David B MacLean, Ling Wang, Hideyuki Akaza, Joel Nelson, Howard I Scher, Robert Dreicer, Iain J Webb, Ronald de Wit, Jan-Erik Damber
  The Lancet. Oncology - 2015
• Urinary Incontinence and Erectile Dysfunction After Robotic Versus Open Radical Prostatectomy: A Prospective, Controlled, Nonrandomised Trial.

  Eva Haglind, Stefan Carlsson, Johan Stranne, Anna Wallerstedt, Ulrica Wilderäng, Thordis Thorsteinsdottir, Mikael Lagerkvist, Jan-Erik Damber, Anders Bjartell, Jonas Hugosson, Peter Wiklund, Gunnar Steineck, Ali Khatami
  European urology - 2015
• Radical prostatectomy versus high-dose irradiation in localized/locally advanced prostate cancer: A Swedish multicenter randomized trial with patient-reported outcomes.

  Bo Lennernäs, Khairul Majumder, Jan-Erik Damber, Per Albertsson, Erik Holmberg, Yvonne Brandberg, Ulf Isacsson, Gunilla Ljung, Ole Damm, Sten Nilsson
  Acta oncologica (Stockholm, Sweden) - 2015
• Prostatacancer - nya riktlinjer och första vårdprogrammet.

  Ola Bratt, Jan-Erik Damber, Anna Aldehag, Helena Brändström
  Läkartidningen - 2015
• Kirurgiska sjukdomar i njurar, urinvägar och prostata (13)

  Jan-Erik Damber, Ralph Peeker
  Njurmedicin / under redaktion av Mattias Aurell och Ola Samuelsson - 2014
• Enzalutamide in metastatic prostate cancer before chemotherapy.

  Tomasz M Beer, Andrew J Armstrong, Dana E Rathkopf, Yohann Loriot, Cora N Sternberg, Celestia S Higano, Peter Iversen, Suman Bhattacharya, Joan Carles, Simon Chowdhury, Ian D Davis, Johann S de Bono, Christopher P Evans, Karim Fizazi, Anthony M Joshua, Choung-Soo Kim, Go Kimura, Paul Mainwaring, Harry Mansbach, Kurt Miller, Sarah B Noonberg, Frank Perabo, De Phung, Fred Saad, Howard I Scher, Mary-Ellen Taplin, Peter M Venner, Bertrand Tombal, Jan-Erik Damber
  The New England journal of medicine - 2014
• Assessment of the bone scan index in a randomized placebo-controlled trial of tasquinimod in men with metastatic castration-resistant prostate cancer (mCRPC).

  Andrew J Armstrong, Reza Kaboteh, Michael A Carducci, Jan-Erik Damber, Walter M Stadler, Mats Hansen, Lars Edenbrandt, Göran Forsberg, Orjan Nordle, Roberto Pili, Michael J Morris
  Urologic oncology - 2014
• Svensk medicinsk forskning behöver inte mer styrning.

  Peter Andersén, Torbjörn Bäckström, Gisela Dahlquist, Jan-Erik Damber, Anna Engström-Laurent, Yngve Gustafson, Paul Hjemdahl, Olle Korsgren, Håkan Olsson, Mikael Wiberg, Anders Widmark
  Läkartidningen - 2014
• Interobserver variability in the pathological assessment of radical prostatectomy specimens: Findings of the Laparoscopic Prostatectomy Robot Open (LAPPRO) study.

  Josefin Persson, Ulrica Wilderäng, Thomas Jiborn, Peter N Wiklund, Jan-Erik Damber, Jonas Hugosson, Gunnar Steineck, Eva Haglind, Anders Bjartell
  Scandinavian journal of urology - 2014

More publications

We have limited the number of publications on this page. Visit GUP (The Publication Database for Gothenburg University) to find more publications.